Bauer, Reinhard (Daiichi Sankyo Europe 200803 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
Germany |
Bauer, Sylvia |
n. a. |
Greiner (Group) |
Germany |
Baule, Rainer (Fresenius 201004 Board Member) |
Board member |
Fresenius (Group) |
Germany |
Bauler, James (Flag Therapeutics 201901 Director Corporate Development) |
Business Development Manager / Strategy Manager |
Flag Therapeutics (US) |
United States (USA) |
Baumann, Matthias (Mologen 201705– CMO before Noxxon + Focus Clinical Drug Development + Roche + BM) |
Chief Medical Officer (CMO) |
Mologen (Group) |
Germany |
Baumann, Oliver R. (Xlife Sciences 202103 CEO) |
Chief Executive Officer (CEO) |
Xlife Sciences AG (SIX: XLS) |
Switzerland |
Baumann, Teresa (GoSilico 202106 Co-Founder) |
Company Founder |
GoSilico GmbH |
Germany |
Baumann, Urs (Bellevue Group 201409 CEO) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
Baumann, Werner (Bayer 201605– CEO before Chief Strategy + Portfolio Officer + CFO joined Bayer1988) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
Baumeister, Hans (FyoniBio 202204 Managing Director before Glycotope 200706– Managing Director COO before BusDev) |
Managing Director |
Canton Biologics (Group) |
Germany |
Baumert, Thomas F. (Univ Stasbourg 201904 Professor + Scientific Founder of Alentis Therapeutics) |
Professor |
University of Strasbourg |
France |
Baumgardt, Jens (Durakult 201107 Managing Director) |
Managing Director |
Durakult GmbH |
Germany |
Baumgart, Holger (Ernst & Young 201603 Partner + Tax Adviser at Ernst & Young GmbH Mannheim) |
n. a. |
Ernst & Young (Group) |
Germany |
Baumgartner, Roland (4SC 201610– promoted CSO joined 2002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Germany |
Baumgartner, Tina (Accella Group 200806– Principal before Guava Technologies + SurroMed + GeneTrace Systems) |
Consultant (economic/technology) |
Accella Group |
United States (USA) |
Baumhauer, Jon (Merck (DE) –201401 Chairman of Family + Executive Board of E Merck RETIRED 1/14) |
Supervisory Board |
Merck (DE) (Group) |
Germany |
Baumstümmler, Bernd (Instillo Group 201507 CEO + MJR PharmJet 201101 Managing Director) |
Managing Director |
MJR PharmJet GmbH |
Germany |
Baur, Andreas (BioLAGO eV 201710 Managing Director) |
Cluster Manager |
BioLAGO e. V. |
Germany |
Baur, Franz (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
Bausch, Alexander (Kinarus 202208 CEO and Strekin 201705 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Strekin AG |
Switzerland |
Bavaj, Paolo (Henkel 201806 Head of Corporate Venturing at Adhesive Technologies business unit) |
Business Development Manager / Strategy Manager |
Henkel (Group) |
Germany |
Baxter, Anthony (Cyprotex 201008 CEO before deltaDOT CEO + Argenta founding CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
United Kingdom (GB) |
Bayerl, Thomas |
n. a. |
University of Würzburg |
Germany |
Baynes, Roy (Merck(US) 201412 SVP Global Clinical Development) |
Research & Development Manager |
Merck (US) (MSD) (Group) |
United States (USA) |
Bazantay, Christian (Servier 201110 Managing Director of Servier Deutschland GmbH) |
Managing Director |
Servier (Group) |
Germany |
Bazemore, Robert (Epizyme 201811 CEO) |
Chief Executive Officer (CEO) |
Epizyme Inc. (Nasdaq: EPZM) |
United States (USA) |
Beator, Jens (SensID 202303 Business Development formerly Stratec Molecular + Protagen + Whatman S&S) |
Managing Director |
SensID GmbH |
Germany |
Beattie, Greg (Charles River 201803 Corp VP Global Biologics Testing Solutions) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
Beaumont, James (Metrion Biosciences 201705– Head Business Development before Evotec + Aptuit) |
Business Development Manager / Strategy Manager |
Metrion Biosciences Ltd. |
United Kingdom (GB) |
Bech Jensen, Ejner (Agrobiomics 202309 CEO before Novozymes 201112 VP RnD) |
Chief Executive Officer (CEO) |
Agrobiomics (DK) |
Denmark |
Beck, Jan-Philipp (EU (govt) 202111 CEO of EIT Health) |
Chief Executive Officer (CEO) |
EU (govt) |
Germany |
Beck, Jürgen (Memo Therapeutics 202306 CMO before prosion + Paion + Intermune + Epigenomics + Synthélabo) |
Chief Medical Officer (CMO) |
Memo Therapeutics AG (MTx) |
Switzerland |
Beck, Matthew L. S. (Matt) (Hookipa 202210 Investor Relations before CureVac + Solebury Trout) |
Public Relations Manager / Investor Relations Manager |
Hookipa (Group) |
United States (USA) |
Beck, Peter (Hölle & Hüttner 200807 Managing Director) |
Managing Director |
HB Technologies (Group) |
Germany |
Beck, Thomas R. (Tom) (Fidelity Biosciences 201406 Executive Partner before Dyax + UCB Pharma) |
Partner (venture partner) |
F-Prime Capital Partners (F-Prime Biosciences) |
United States (USA) |
Becker, Bernard (InterMed Discovery 200810 Managing Director) |
Managing Director |
InterMed Discovery GmbH (IMD) |
Germany |
Becker, Chris (Protein Metrics 201209 CEO) |
Chief Executive Officer (CEO) |
Insightful Science (Group) |
United States (USA) |
Becker, Frank (Intana Bioscience 200907 Managing Director + Founder) |
Managing Director |
Intana Bioscience GmbH |
Germany |
Becker, Marc (CRISPR Therapeutics 201603– CFO before rEVO Biologics + Genzyme) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
Becker, Mario (Sartorius 202308 Head of Product Group Bioreactor Technologies) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
Becker, Sabine (Helmholtz 200912– Head BrainMet Competence Centre) |
Research & Development Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Becker, Thomas |
n. a. |
Eurofins (Group) |
Germany |
Beckerling, Andree (Accovion 201504 Managing Director (CEO)) |
Managing Director |
Clinipace (Group) |
Germany |
Beckman, Evan (Novartis 201803 Head of Translational Medicine at Novartis Institutes for BioMedical Research) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
Beckman, Peter (Kiel (govt) 201204 Managing Director of KiWi GmbH + KiWi Tower GmbH) |
Managing Director |
|
Germany |
Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources) |
Board member, executive |
Merck (DE) (Group) |
Germany |
Beckmann, Roland (Dutalys GmbH 201412 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Roche (Group) |
Austria |
Bednarczuk, Piotr (Merck KGaA 201110– Head Corporate Human Resources) |
Human Resources Manager |
Merck (DE) (Group) |
Germany |
Bedoret, Denis (Imcyse 202009– CEO before MaSTherCell + Quality Assistance SA + McKinsey & Co) |
Chief Executive Officer (CEO) |
Imcyse S.A. |
Belgium |
Beecher, Chris (IROA Technologies 201309 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
IROA Technologies LLC |
United States (USA) |
Beeler, Kristina (Biognosys 202105– CBO before Head of Business Development joined 2017 before Nextech Invest) |
Chief Business Officer (CBO) |
Bruker (Group) |
Switzerland |
Beerhalter, Stefan B. (Germany (govt) 201802– VP Germany at GALS before Cardionovum GmbH + OrbusNeich Medical) |
Business Development Manager / Strategy Manager |
Germany (govt) |
Germany |
Beery, Matan (Akvolution GmbH 201310– Managing Director) |
Managing Director |
Akvolution GmbH (Akvola Technologies) |
Germany |
Beguir, Karim (InstaDeep 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
InstaDeep (Group) |
United Kingdom (GB) |
Behar, Greg (Nestlé 201509 CEO of Nestlé Health Science) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
Behbahani, Ali (New Enterprise Associates 201504) |
Investment Manager |
New Enterprise Associates (NEA) |
United States (USA) |
Beher, Dirk (Asceneuron 201509 CEO) |
Chief Executive Officer (CEO) |
Asceneuron S.A. |
Switzerland |
Behn, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
Behnke, Detlev (ProThera=Wacker Biotech 200501 Managing Director) |
Managing Director |
Wacker (Group) |
Germany |
Behr, Pascal (Cytosurge 201806 CEO) |
Chief Executive Officer (CEO) |
Cytosurge AG |
Switzerland |
Behrenbruch, Christian (Telix 201511– CEO before ImaginAb CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Telix Pharmaceuticals Ltd. (ASX: TLX) |
Australia |
Behrendt, Dominik (SeSaM-Biotech 201011– Managing Director) |
Managing Director |
SeSaM-Biotech GmbH |
Germany |
Behrendt, Ulrich (Roche Diagnostics 200706 also VBU Board Member Chairman 200706) |
n. a. |
Roche (Group) |
United States (USA) |
Behrens, Jeff (Siamab Therapeutics 201710 CEO) |
Chief Executive Officer (CEO) |
Siamab Therapeutics Inc. |
United States (USA) |
Behrens, Jens (Eppendorf AG 200607 Director Electronic Communications) |
n. a. |
Eppendorf (Group) |
Germany |
Behrens, Kai (Bruker 201706 Head XRF Product Management at Bruker AXS) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
Behrens, Sven-Erik (Univ Halle 201805 Professor + VeroVaccines GmbH 201805 Managing Director + Co-Founder) |
Professor |
University of Halle (Martin-Luther Universität Halle-Wittenberg) |
Germany |
Beier, Cornelia (Leon-Nanodrugs 201010– Managing Director + Co-Founder) |
Managing Director |
H.A.C. Pharma (FR) |
Germany |
Beier, Karolin (Biosaxony 201504 Event Manager) |
Event Manager / Conference Manager |
Biosaxony Management GmbH |
Germany |
Beier, Markus (febit 200704 Director Customer Care) |
n. a. |
Hummingbird Diagnostics GmbH |
Germany |
Beier, Wolfgang (Leon-Nanodrugs 201010– Medical Director + Co-Founder) |
Chief Medical Officer (CMO) |
H.A.C. Pharma (FR) |
Germany |
Beil-Peter, Manuela (Endress+Hauser 201801 Director of Lab Automation + Liquid Handling at Analytik Jena) |
President/Director/Head Business Group/Unit/Division |
Endress+Hauser (Group) |
Germany |
Beils, Fernando (Siemens 201712 Head of Molecular Diagnostics at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Germany |
Beim, Piraye Yurttas (Celmatix 201910 CEO + Founder) |
Chief Executive Officer (CEO) |
Celmatix Inc. |
United States (USA) |
Beisiegel, Ulrike (Univ Göttingen 201301 President) |
n. a. |
University of Göttingen (Georg August University) |
Germany |
Beitl, Michael (Kern Tec 202309 Managing Director + Co-Founder) |
Managing Director |
Kern Tec GmbH |
Austria |
Beitz, Wolfgang (Siemens 200801– CFO Healthcare Division Workflow & Solutions before Head Bus Admin Siemens Japan) |
Chief Financial Officer (CFO) |
Siemens (Group) |
Germany |
Belani, Ravi (Alchemist Accelerator 201902 Managing Director) |
Managing Director |
Alchemist Accelerator (US) |
United States (USA) |
Belawat, Priyanka (HBM 201806 Investment Advisor at HBM Partners) |
Consultant (economic/technology) |
HBM (Group) |
Switzerland |
Belaya, Julia (Plug and Play 201809 Director Health) |
n. a. |
Plug and Play (Group) |
United States (USA) |
Belcredi, Alexander (PhagoMed 201906 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
Austria |
Beleta, Jorge (Almirall 201109 Director Discovery Strategy and Alliances) |
Business Development Manager / Strategy Manager |
Almirall (Group) |
Spain (España) |
Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Mérieux (Group) |
France |
Beljaars, Alexander (IUL Instruments 200812 Managing Director) |
Managing Director |
IUL Instruments GmbH |
Germany |
Bell, Mathias (c-LEcta 201207 Senior Business Development Manager) |
Business Development Manager / Strategy Manager |
Kerry Group (Group) |
Germany |
Bellemin, Jean-Marc (Gritsone Oncology 201801– CFO before Actelion + Guerbet) |
Chief Financial Officer (CFO) |
Gritstone Oncology Inc. |
United States (USA) |
Beller, Maggie (Russo Partners 201808) |
Public Relations Manager / Investor Relations Manager |
Russo Partners LLC |
United States (USA) |
Bellotto, Manolo (Gain Therapeutics 202009 President + General Manager) |
General Manager (management) |
Gain Therapeutics (Group) |
Switzerland |
Bellstedt, Peter (Univ Jena 201806 Head of NMR platform) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
Belvisi, Maria (Imperial College London 201203 Prof + Director of IR Pharma Ltd) |
Professor |
Imperial College London |
United Kingdom (GB) |
Belzer, Ilana (Procognia 201207 VP RnD + Operations) |
Research & Development Manager |
Procognia (Group) |
United Kingdom (GB) |
Ben Lekhal, Anja (Evotec 202104 Investor Relations Associate before Kirchhoff Consult 201509) |
Public Relations Manager / Investor Relations Manager |
Kirchhoff Consult AG |
Germany |
Ben-Asher, Dror (RedHill BioPharma 201406 CEO) |
Chief Executive Officer (CEO) |
RedHill Biopharma Ltd. (Nasdaq: RHDL) |
Israel |
Ben-Yossef, Yossi (Kadimastem Ltd 201204 CEO) |
Chief Executive Officer (CEO) |
Kadimastem Ltd. |
Israel |
Ben-Zeev, Iris (Kenes 201308 Event Manager) |
Event Manager / Conference Manager |
Kenes (Group) |
Switzerland |
Benaich, Nathan (Air Street Capital 202103 General Partner) |
General Partner (venture partner) |
Air Street Capital (Nathan Benaich) |
|
Bender, Joe (Capsulution 200811– CEO before Bayer) |
Chief Executive Officer (CEO) |
Capsulution (Group) |
Germany |
Bender, Manfred (BRAIN 201812–202009 CFO before Pfeiffer Vacuum CEO before CFO LEFT 9/20) |
Chief Financial Officer (CFO) |
BRAIN Biotech (Group) |
Germany |
Bender, Norbert (Evolva 201105– CMO before ViroLogik + Trigen + Carion + Hoechst + Knoll) |
Chief Medical Officer (CMO) |
Evolva (Group) |
Switzerland |
Bendisch, Roger (Berlin (govt) 201111 Managing Director IBB Beteiligungsgesellschaft) |
Managing Director |
Berlin (govt region) |
Germany |